Trial Site Detail
Drug: |
IPI-504 |
|||
|---|---|---|---|---|
Trial: |
Safety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS) |
|||
| Conditions: | Gastrointestinal Stromal Tumors; Soft Tissue Sarcomas | |||
Trial Status: |
Completed |
|||
Premier Oncology, Scottsdale9023 E. Desert Cove Ave. Suite 101 |
Principal Investigator: |
Michael S Gordon, MD |
|---|---|
Contact: |
480 480-5000 480 882-0130 |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Premier Oncology, Scottsdale Website: |
http://www.premiereoncology.com/po/index.php?option=com_content&task=category§ionid=4&id=67&Itemid=55 |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.